CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group-Reference-Cited by-同舟云学术

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Published:2006-05 Issue:5 Volume:7 Page:379-391
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Pfreundschuh Michael,Trümper Lorenz,Österborg Anders,Pettengell Ruth,Trneny Marek,Imrie Kevin,Ma David,Gill Devinder,Walewski Jan,Zinzani Pier-Luigi,Stahel Rolf,Kvaloy Stein,Shpilberg Ofer,Jaeger Ulrich,Hansen Mads,Lehtinen Tuula,López-Guillermo Armando,Corrado Claudia,Scheliga Adriana,Milpied Noel,Mendila Myriam,Rashford Michelle,Kuhnt Evelyn,Loeffler Markus

Publisher

Elsevier BV

Subject

Oncology

Reference16 articles.

1. A predictive model for aggressive non-Hodgkin's lymphoma;N Engl J Med,1993

2. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma;Miller;N Engl J Med,1998

3. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL;Pfreundschuh;Blood,2004

4. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma;Reyes;N Engl J Med,2005

5. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

Cited by 1767 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world Outcomes of Diffuse Large B-cell Lymphoma Treated with frontline R-CHOP(-like) regimens in an Asian Multi-ethnic Population;2024-09-11

2. Safety of Rituximab biosimilar (Riximyo®) following a single switch from the reference product in patients with Non-Hodgkin’s lymphoma: a retrospective study;Annals of Hematology;2024-09-09

3. Safety and Efficacy of Bispecific Antibodies in Adults with Large B-Cell Lymphomas: A Systematic Review of Clinical Trial Data;International Journal of Molecular Sciences;2024-09-09

4. An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma;Annals of Hematology;2024-09-04

5. FCGR3A polymorphism : It is helpful for the management of diffuse large B-cell lymphoma;2024-09-02